throbber
870
`
`UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF NEW JERSEY
`
`ASTRAZENECA PHARMACEUTICALS
`
`LP, et al.,
`
`Plaintiffs/Counterclaim—
`Defendants,
`
`CIVIL ACTION NUMBERS:
`
`-vs-
`
`14—cv—O3547—RMB—KMW
`
`INC.,
`SAGENT PHARMACEUTICALS,
`Defendant/Counterclaim-Plaintiff.
`
`ASTRAZENECA PHARMACEUTICALS
`
`LP, et al.,
`
`Plaintiffs/Counterclaim—
`Defendants,
`
`GLENMARK GENERICS,
`
`INC. , USA,
`
`14-CV-05539-RMB-KMW
`
`Defendant/Counterclaim-Plaintiff.
`
`15-CV-00615-RMB-KMW
`
`Mitchell H. Cohen United States Courthouse
`
`One John F. Gerry Plaza
`Camden, New Jersey 08101
`July 14, 2016
`
`B E F O R E:
`
`THE HONORABLE RENEE MARIE BUMB
`UNITED STATES DISTRICT JUDGE
`AND A JURY
`
`C)\oQ)‘Q0\U1uhI»K)IA
`
`B:
`
`|~\ |~\
`
`H K)
`
`F: U)
`
`B: &
`
`F: U!
`
`FA 0\
`
`FA \J
`
`F: G)
`
`F: ‘O
`
`K) C)
`
`K) F1
`
`R)R)
`
`R) h)
`
`K) wk
`
`K) U1
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 1
`Mylan Pharms. Inc. V. Astrazeneca AB IPR2016-01325
`
`

`
`C)\oQ)‘Q0\U1uhI»K)IA
`
`B:
`
`|~\ |~\
`
`H K)
`
`F: U)
`
`FA IA
`
`F: U!
`
`FA 0\
`
`FA \J
`
`F: G)
`
`F: ‘O
`
`K) C)
`
`K) F1
`
`R)R)
`
`R) h)
`
`K) wk
`
`K) U1
`
`871
`
`A P P E A R A N C E S:
`
`WCCARTfiR &
`
`fiNGR SH
`
`3Y:
`
`John E. Flaherty. Esquire
`Ravin R. Patel, Esqiire
`Attorneys For AstraZeneca
`
`O'MfiLVfiNY & MYERS LLP
`
`QY: Lisa Rarons Pensabene, Esquire
`"ill C. Aitz, Esqiire
`Carolyn Wall, Esqiire
`?ber'e R. Schultz, Esquire
`Daniel O'?oyle, Esqiire
`Eric S. Santoro, Esquire "n House Counsel
`Attorneys for AstraZeneca
`
`CARELLA, %YRNfi, CfiCCH , oLsT« N, %RODY & AGNELLO
`
`3Y: Melissa E. Flax, Esquire
`Christopher J. Biggy, Esquire
`Attorneys for Sagent Pharmaceuticals,
`Generics Inc., USA
`
`FOLEY & LAQDNER LLP
`
`3Y:
`
`Steven J. Rizzi, Esquire
`Liane W. Peterson, Esquire
`Debra Lange, Esquire
`{any Rizkalla, Esquire
`Attorneys for Sagent Pharmaceuticals,
`Generics Inc., USA
`
`Inc., and Glenmark
`
`Inc., and Glenmark
`
`Certified as true and correct as required by Title 28,
`.C., Section 753.
`
`/S/ Theodore M. Formaroli, CSR, CRR
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 2
`
`

`
`3 VYfiSH Mfi{TA
`
`3 RfiCT fiXAW NAT ON OH 3 VYfiSH MfiHTA %Y MS
`BfiTfi?SOW:
`CROSS—fiXAW NAT ON OF DR. M%HTA %Y MS. BfiNSA fiNfi
`Rfij RfiCT fiXAM NAT ON OF DR. MfiHTA %Y MS
`BfiTfi?SOW:
`
`872
`
`949
`
`950
`
`L048
`L104
`
`Q\OQ)\l0\U1vl:b.)'\)|~\
`
`H
`
`|~\ |~\
`
`H K)
`
`H U.)
`
`H IA
`
`H U‘!
`
`H 0\
`
`|~\ \l
`
`H U)
`
`H KO
`
`K) C)
`
`K) H
`
`R)R)
`
`R) Q)
`
`N is
`
`K) U1
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 3
`
`

`
`‘OQ)‘Q0\U1:5InK)IA
`
`H Q
`
`|~\ |~\
`
`H K)
`
`F: U)
`
`H IA
`
`F: U!
`
`H 0\
`
`|~\ \l
`
`H U)
`
`H KO
`
`K) C)
`
`K) H
`
`R)R)
`
`R) h)
`
`K) A
`
`K) U1
`
`873
`
`912
`
`949
`
`959
`
`1023
`
`1039
`
`10.0
`
`10-7
`
`% TS DTX-545, 546 AND 548 "fi?fi
`fiV DfiNCfi
`
`TS JTX-6,
`fiV DfiNCfi
`% T DTX-276 WAS ?fiCfi VfiD
`
`JTX-7, AND JTX-8 WfiRfi
`
`W
`
`fiX
`
`JTX-13,
`% TS' BTX-392, DTX-285,
`-8,
`JTX—l6, 3Tx—49,
`JTX— 7,
`JTX—l5,
`JTX-14, and JTX-TO Wfl?fi RfiCfi VfiD
`N
`
`«X
`:
`ex
`
`4 TS 3Tx—433, 881, 309, 320 AND 311
`W fiV 3%NCfi
`4 TS 3Tx—317 AND 3Tx—318 "wRa
`:V DfiWCfi
`
`JTX—4, PTX—432,
`JTX—3,
`4 TS dTX—l,
`ex
`3Tx—287, 3Tx—306 and 3Tx—30/ wnau
`%V DfiWCfi
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 4
`
`

`
`DEPOS T ON - MCPESKEY
`
`874
`
`THE DEPUTY CLERK: All rise.
`
`(OPEN COURT, Jily 14, 2016, 9:08 a.m.)
`
`TEE COURT:
`
`Good morning.
`
`RESPONSE: Good morning, Your Honor.
`
`TEE COURT: Have a seat.
`
`Okay. Are we ready to continue with the deposition
`
`testimony?
`
`MS. P"ROHHOLO—MfiLLOWES: Yes, we are, Your Honor.
`
`TEE COJRT: Ms. McCleskey,
`
`come forward.
`
`MR. PRE TAS: Yes, Your Honor.
`
`(Laighter.)
`
`TEE COJRT:
`
`Good morning.
`
`MR. PRE TAS: Good morning.
`
`TEE COJRT: Okay. Whenever you're ready.
`
`MS. P"ROHHOLO—MfiLLOWfiS: We 1e"L o"" at Page 140 of
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`09MmAM
`
`09MWAM
`
`09MWAM
`
`16 the transcript.
`
`17
`
`18
`
`THE COURT: Yes,
`
`thank you.
`
`MS. P"ROHHOLO—MfiLLOWES: And Ms. Waldron continues
`
`19
`
`the questioning on beha'" o" de"endants.
`
`09MWAM
`
`20
`
`(Deposition read as ‘o1'ows:)
`
`21 Q. Let's get back -o -he documents you kept when you were at
`
`22
`
`the Lombardi Cancer Center.
`
`23
`
`Did I understand you to say that you did keep
`
`24
`
`laboratory notebooks?
`
`09MWAM
`
`25 A.
`
`Yes.
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 5
`
`

`
`D*'.L’OS T ON - MCT.*'.SK+'.Y
`
`875
`
`1 Q.
`
`Did you have any raw data of any kind?
`
`2 A.
`
`It was in the laboratory notebooks.
`
`3 Q.
`
`It would be pasted in the lab notebooks?
`
`4 A.
`
`Why do you think raw data would not be on the same piece
`
`09mmAM
`
`5 of paper as the lab notebook?
`
`6 Q. Actually,
`
`I don't know one way or the other.
`
`I want
`
`to
`
`7
`
`know what your particular procedure was.
`
`8 A. Well, most of the time, you're writing the laboratory
`
`9 notebook.
`
`"‘ you get,
`
`like,
`
`a printout or something,
`
`then you
`
`09mmAM 10 would paste .hat
`
`in -he laboratory notebook.
`
`11 Q.
`
`Got it. Did yoi keep anything on the computer?
`
`12 A.
`
`Yes.
`
`13 Q. What did you keep on the computer?
`
`14 A. Well,
`
`remembering that computers were not as good as they
`
`09n0AM 15
`
`are now, when I got data,
`
`I would have to enter it into the
`
`16 computer,
`
`like,
`
`into a graphing program,
`
`‘or instance, and
`
`17
`
`then it would draw the graph and I would print the graph. But
`
`18
`
`the —— but
`
`the data in the computer was the same as in my --
`
`19 hopefully, as in my lab notebook.
`
`09fl0AM 20 Q.
`
`You didn't create, say, Word files and keep them on a
`
`21
`
`computer?
`
`22 A.
`
`Oh, yes, but that's not data.
`
`23 Q.
`
`Okay.
`
`I see. What
`
`type o" in"ormaLion or documents,
`
`if
`
`24
`
`any, would you have saved on a computer?
`
`09n0AM 25 A.
`
`The dra"Ls o" the paper,
`
`the —— atter " entered the data
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 6
`
`

`
`DfiBOS T
`
`ON - MCPfiSKfiY
`
`876
`
`to make a graph,
`
`that would be saved, of course, but it would
`
`be the data jrom the lab notebook that
`
`entered.
`
`So it's,
`
`like,
`
`a copy and —— and also the graphics tile, picture a
`
`graph.
`
`I don't know how you would say that, but
`
`the graph
`
`09flflAM
`
`itse",
`
`" guess you would say,
`
`that was saved to the computer.
`
`%ut
`
`also, of course, printed it.
`
`Q.
`
`3o you have knowledge as to whether anyone in your group
`
`had documents saved to a computer that had originated from
`
`AstraZeneca?
`
`09fllAM
`
`A.
`
`i don't have knowledge
`
`about anybody else in my group
`
`"I me.
`
`Did you have any documents originating
`
`from AstraZeneca
`
`that related to Ms. McCleskey 1998 saved to a computer?
`
`09fllAM
`
`09fllAM
`
`K3D9K3D9K3D9K33’
`
`Are you speaking about
`
`data?
`
`Anything.
`
`For example
`
`Saved to a computer?
`
`Yeah,
`
`like a statement
`
`o_ proposed investigation --
`
`Oh, no --
`
`—— sample requests?
`
`—— no, no.
`
`Did you have data that
`
`originated from AstraZeneca saved
`
`computer?
`
`Wo.
`
`Did you have any binders or personal notebooks separate
`
`09fllAM
`
`from your lab notebooks in which you kept
`
`information
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 7
`
`

`
`D*'.L’OS T ON - MCT.*'.SK+'.Y
`
`877
`
`regarding McLeskey 1998?
`
`A.
`
`I had binders with the tumor data,
`
`the tumor measurements
`
`in pictures of mice.
`
`Q.
`
`Any other places where you would have had information
`
`09 HAM
`
`related to McLeskey 1998,
`
`that we haven't talked about?
`
`A.
`
`No.
`
`Q.
`
`Now, you mentioned,
`
`if " understood you correctly,
`
`believe you testified that you destroyed your technical
`
`documents related to McLeskey 1998 in the beginning of
`
`09fl2AM
`
`June 2014;
`
`is that right?
`
`A. Correct.
`
`Q. What did you mean by "destroyed?"
`
`How did you destroy
`
`them?
`
`A.
`
`just threw them in the trash.
`
`09fl2AM
`
`Q.
`
`Just a regular trash bin?
`
`A.
`
`Yeah.
`
`Q. Where was this trash bin?
`
`A.
`
`At my school.
`
`Q. What school?
`
`09fl2AM
`
`A.
`
`The University of Maryland School of Nursing.
`
`Q.
`
`Do you know what happened to the documents after you
`
`threw them in the trash bin?
`
`A.
`
`No.
`
`Q. When you left Lombardi Center and took your technical
`
`09fl2AM
`
`documents with you, was it your understanding that that was
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 8
`
`

`
`DfiBOS T
`
`ON - MCPfiSKfiY
`
`878
`
`C)\oQ)‘Q0\U1uhI»K)IA
`
`09fl2AM
`
`09fl3AM
`
`B:
`
`okay by the rules,
`
`by Lombardi's policies?
`
`A.
`
`Q.
`
`i didn't have any understanding about that.
`
`Did you know what document retention policies Lombardi
`
`would have had in place at the time?
`
`A.
`
`No.
`
`Q. When you --
`
`I'll just say "you" to start,
`
`and‘
`
`will be talking about
`
`Lombardi Center.
`
`When you got a
`
`document on a project, say,
`
`a
`
`certijicate o_
`
`service or MSDS
`
`or something like that,
`
`what did you do with it?
`
`Where was
`
`something like that kept?
`
`F1 F1
`
`A.
`
`i don't know what a certijicate oj service is.
`
`F1 K)
`
`F: U)
`
`The —— we were required to keep MSDSs
`
`in the notebook
`
`in the lab for all chemicals that we had in the lab,
`
`so that's
`
`FA Q
`
`what we did.
`
`09fl3AM
`
`F: U!
`
`So MSDSs would be kept
`
`in the laboratory notebooks,
`
`H: 0\
`
`correct?
`
`09fl3AM
`
`FA \J
`
`F: G)
`
`F: ‘O
`
`K) C)
`
`K) F1
`
`R)R)
`
`R) h)
`
`K) wk
`
`(Reading stopped.)
`
`MR. ERfi TAS:
`
`' apologize.
`
`T{E COJRT: Ask it again.
`
`MS . P"?O'.'.OT.O-M+1T.T.OW+1S :
`
`You have to read —— he
`
`inadvertently reread the question.
`
`T{E COURT: Yes.
`
`(Deposition read as follows:)
`
`Q.
`
`So MSDSs would be kept
`
`in the laboratory notebooks,
`
`09fl3AM
`
`K) U1
`
`correct?
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 9
`
`

`
`DfiBOS T ON - MCPfiSKfiY
`
`879
`
`A.
`
`No, not
`
`in —— not where we had the data. We had separate
`
`noteboo< for MSDSs.
`
`.
`
`MSDSs had their own notebook?
`
`That's correct.
`
`"ha: about cerLijica-es o_ analysis?
`
`Didn't usually keep
`
`those.
`
`They're
`
`—— why not?
`
`Didn't
`
`feel that we needed them.
`
`"ho retained custody o:
`
`documents as they came in on the
`
`<ey l998 project?
`
`i don't
`
`know what you're talking about, what documents.
`
`Do you recall how samples got shipped into
`
`-he "aci'ity,
`
`whether,
`
`say,
`
`they went
`
`to a mailroom or a specific sample
`
`depos
`
`itory?
`
`They went
`
`to the mailroom.
`
`And then that —— that would happen?
`
`The mail people would bring them to us.
`
`Would you then keep the samples in your lab?
`
`Yes.
`
`And did I
`
`understand you correctly that at the time you
`
`were a postdoc in
`
`Dr. Kern's lab, you were not aware of the
`
`policies and procedures that Lombardi Center had in place with
`
`C)\oQ)‘Q0\U1uhI»K)IA
`
`09fl3AM
`
`09flAAM
`
`B:
`
`F1 F1
`
`F1 K)
`
`F: U)
`
`FA Q
`
`F: U!
`
`H: 0\
`
`FA \J
`
`F: G)
`
`F: ‘O
`
`K) C)
`
`K) F1
`
`R)R)
`
`09flAAM
`
`09flAAM
`
`R) h)
`
`regar
`
`d to retention o:
`
`documents;
`
`is that right?
`
`K) wk
`
`A.
`
`No: only was
`
`i not aware o: anything they had in place,
`
`09flAAM
`
`K) U1
`
`was not aware i:
`
`—— whether they had anything in place.
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 10
`
`

`
`D*'.L’OS T ON - MCT.*'.SK+'.Y
`
`880
`
`1 Q.
`
`"‘ you received ancillary paperwork with samples, such as
`
`2
`
`a certijicate oj analysis or something like that, what would
`
`3
`
`4
`
`5
`
`6
`
`09fl5AM
`
`you hav
`
`r cord d th r c ipt oj
`
`-haL document --
`
`(Reading stopped.)
`
`T{E COURT:
`
`"Would you."
`
`(Deposition read as follows:)
`
`7 Q. Would you hav
`
`r cord d th r c ipt of that document
`
`in
`
`8
`
`your laboratory notebook?
`
`9 A.
`
`Wo.
`
`09fl5AM 10 Q.
`
`Did Lombardi
`
`require you to make copies of anything and
`
`11
`
`send them on to a document repository or anything like that?
`
`12 A.
`
`W0.
`
`13 Q.
`
`To your knowledge, were the documents that you were
`
`14
`
`keeping in your lab the only copies?
`
`09fl5AM 15 A.
`
`As tar as " knew.
`
`16 Q.
`
`Are you aware of whether copies were ever made of your
`
`17
`
`laboratory notebooks?
`
`18 A.
`
`think not.
`
`19 Q.
`
`"ho had access to your laboratory notebooks besides you?
`
`O9fl5AM 20 IX.
`
`iDr. Kern.
`
`21 Q.
`
`Anyone else?
`
`22 A. Well,
`
`the other people in the lab would have, had they
`
`23 wanted it, but
`
`I don't know that they ever did --
`
`24
`
`(Reading stopped.)
`
`09fl5AM 25
`
`T{E COURT:
`
`So could have.
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 11
`
`

`
`D*'.L’OS T ON - MCT.*'.SK+'.Y
`
`881
`
`1
`
`2
`
`MR. ERfi TAS:
`
`Pardon me.
`
`(Deposition read as follows:)
`
`3 A. Well,
`
`the other people in the lab could have had they
`
`4 wanted it, but
`
`I don't know what
`
`they ever did —— that they
`
`09fl5AM
`
`5
`
`ever did.
`
`6 Q.
`
`In the conversation that you just referred to, when you
`
`7
`
`communicated with Mr. Trock, what did you discuss with
`
`8 Mr. Trock?
`
`9 A.
`
`He —— I
`
`think he,
`
`I don't remember a whole lot about
`
`the
`
`09flfiAM 10
`
`conversation, but he said that he had been just about
`
`to
`
`11 discard the data from —— from this paper when they called.
`
`12 Q. When who ca"ed?
`
`13 A.
`
`The —— the lawyers that were doing the Teva thing, Mary
`
`14 Burke and company.
`
`09fl6AM 15 Q.
`
`I'm sorry.
`
`I believe you just said,
`
`"Mary 3urke did not
`
`16 ask me not
`
`to destroy documents."
`
`17 A.
`
`She did not say, Don't destroy documents. When she said
`
`18
`
`that,
`
`I do not know.
`
`19 Q. Mary 3urke never told you to preserve your documents
`
`09nfiAM 20
`
`related to McLeskey 1998?
`
`21 A. Correct.
`
`22 Q.
`
`Did anyone Mary 3urke worked with ever tell you not
`
`to --
`
`23 tell you that you must preserve your documents related to
`
`24 McLeskey 1998?
`
`09:16AM 25 A.
`
`No.
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 12
`
`

`
`DfiBOS T
`
`ON - MCPfiSKfiY
`
`882
`
`Now,
`
`i believe you said earlier that you recall speaking
`
`with three people at AstraZeneca,
`
`Dr.
`
`Wakeling,
`
`Dr.
`
`Vose,
`
`and
`
`a third person whose name you don't
`
`remember;
`
`is that correct?
`
`Correct.
`
`Do you recall
`
`approximately how many times you spoke with
`
`Dr.
`
`Wakeling?
`
`Twice.
`
`Was
`
`I)
`this via telephone or by some other means o;
`
`communication?
`
`Telephone.
`
`Who called who?
`
`called him.
`
`Both times?
`
`Yes.
`
`Why did you call
`
`Dr.
`
`Wakeling?
`
`The ‘irst time
`
`called to ge
`
`t him to send me the drug
`
`C)\oQ)‘Q0\U1uhI»K)IA
`
`09flfiAM
`
`09fl7AM
`
`B:
`
`F1 F1
`
`F1 K)
`
`F: U)
`
`FA h
`
`F: U!
`
`H: 0\
`
`09fl7AM
`
`FA \J
`
`and
`
`find out how to administer it
`
`to mice.
`
`The second time
`
`F: G)
`
`called
`
`to tell him we had used the drug he sent
`
`the
`
`first time
`
`F: ‘O
`
`and
`
`that i needed more drug.
`
`09fl7AM
`
`K) C)
`
`Q.
`
`Did Dr. Wakeling require you to
`
`fill out any paperwork or
`
`K) F1
`
`do anything in writing be:
`
`fore you received samples o:
`
`drugs?
`
`R)R)
`
`A.
`
`Wot me.
`
`R) h)
`
`Q.
`
`Did he require that someone
`
`I)
`fill out some sort o;
`
`K) wk
`
`paperwork be:
`
`fore samples would be shipped?
`
`09fl7AM
`
`K) U1
`
`A.
`
`i don't know.
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 13
`
`

`
`DfiBOS T
`
`ON - MCPfiSKfiY
`
`883
`
`C)\oQ)‘Q0\U1uhI»K)IA
`
`09fl7AM
`
`09fiWAM
`
`B:
`
`F1 F1
`
`F1 K)
`
`F: U)
`
`FA Q
`
`Q.
`
`What did Dr.
`
`Wakeling tell you in response to your
`
`request
`
`I)
`that you wanted AstraZeneca to send you samples o;
`
`drugs?
`
`A.
`
`He told me that
`
`should give it to the mice as it
`
`outlined in this paper and that he would ship it.
`
`Q.
`
`3asically, an okay—I'll—take—care—of—it
`
`type thing?
`
`A.
`
`Jm—hum.
`
`Q.
`
`{ow many times did you speak with Dr. Vose?
`
`A.
`
`Once —— that —— assume that he was not
`
`the second —— the
`
`person I don‘: know who it is, but --
`
`Q . Right.
`
`A.
`
`——
`
`know I spoke with him once.
`
`Q.
`
`Did you ever communicate with Dr. Wakeling in writing
`
`either by e—mail or letter?
`
`09fiWAM
`
`F: U!
`
`A.
`
`Not that
`
`reca'l.
`
`FA 0\
`
`FA \J
`
`F: G)
`
`F: ‘O
`
`K) C)
`
`K) F1
`
`R)R)
`
`R) h)
`
`K) wk
`
`K) U1
`
`09fiWAM
`
`09fiWAM
`
`Q.
`
`Okay.
`
`So you said you spoke with Dr. Vose once;
`
`is that
`
`right?
`
`Um—hum.
`
`Was this on the phone?
`
`Yes.
`
`Did you ever have any written communications with him?
`
`Wot
`
`to my —— not that i remember.
`
`On the one incident —— one instance that you did speak
`
`Dr. Vose, who called who?
`
`called him.
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 14
`
`

`
`DfiBOS T ON _ MCTI*: SKfiY
`
`884
`
`C)\oQ)‘Q0\U1uhI»K)IA
`
`09fiWAM
`
`09fl9AM
`
`B:
`
`Q.
`
`"hy did you call Dr. Vose?
`
`A.
`
`Because Dr. Wakeling told me to call him to get
`
`pre‘ormu'ated drug.
`
`Q.
`
`Do i understand that you talked to Dr. Wakeling about
`
`receiving powdered
`
`C
`
`187,780 and Dr. Vose about obtaining
`
`preformulated C
`
`187,780?
`
`A.
`
`At separate times.
`
`Q.
`
`I'm jus- trying to understand.
`
`think " understand the
`
`—— that you talked to these guys about
`
`two di""erenL things.
`
`Do
`
`inderstand correctly that you tal<ed to
`
`F1 F1
`
`Dr. Wakeling about receiving powdered
`
`C
`
`187,780?
`
`F1 K)
`
`A. Correct.
`
`F: U)
`
`FA IA
`
`Q.
`
`And then do i understand correctly that you talked to
`
`Dr. Vose aboit receiving the pre‘ormu'ated C
`
`187,780?
`
`09fl9AM
`
`F: U!
`
`A. Much later.
`
`FA 0\
`
`FA \J
`
`F: G)
`
`Q. Much later? That's a good point.
`
`Do yoi reca11
`
`approximate1y when,
`
`or do you recall the
`
`approximate dates on which you talked to
`
`Dr. Wakeling?
`
`F: ‘O
`
`A.
`
`No.
`
`09fl9AM
`
`K) C)
`
`Q.
`
`Year?
`
`K) F1
`
`A.
`
`i don't know.
`
`R)R)
`
`Q.
`
`But you know you talked to
`
`Dr.
`
`Vose much later.
`
`What do
`
`R) h)
`
`you mean by "much later?"
`
`K) wk
`
`A. When :
`
`talked to Dr.
`
`Wakeling initially,
`
`then he sent me
`
`09fl9AM
`
`K) U1
`
`the drug,
`
`then we used the drug in mice and also in in vitro
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 15
`
`

`
`DfiBOS T
`
`ON - MCPfiSKfiY
`
`885
`
`studies and we used it all up.
`
`So
`
`T don't know how long that
`
`took, but
`
`i would say a matter o:
`
`: months,
`
`anyway, maybe a
`
`year.
`
`Then we needed more drug so
`
`called Dr. Wakeling
`
`again,
`
`that's when he to:
`
`_d me to call
`
`Dr. Vose.
`
`Q.
`
`And the powdered
`
`C
`
`187,780 would have been what you --
`
`what was dissolved in ethanol and then spiked into the peanut
`
`oil?
`
`A. Correct.
`
`Q. When you spoke to
`
`Dr.
`
`Vose,
`
`what did he tell you about
`
`shipping you samples o
`
`" pre"ormulated l82,780?
`
`C)\oQ)‘Q0\U1uhI»K)IA
`
`09:20AM
`
`09:20AM
`
`B:
`
`F1 F1
`
`A.
`
`{e said he would.
`
`F1 K)
`
`F: U)
`
`FA IA
`
`F: U!
`
`09:20AM
`
`Q.
`
`Did he say anything else?
`
`A. Wot
`
`to my remembrance.
`
`Q.
`
`Did he require that you do anything before he sent
`
`the --
`
`sent
`
`-he "files o" pre
`
`"ormulated
`
`C
`
`187,780?
`
`H: 0\
`
`A.
`
`Wo
`
`FA \J
`
`Q.
`
`Do you know whether anyone in your lab had to complete
`
`F: G)
`
`F: ‘O
`
`any type of paperwork be:
`
`fore AstraZeneca would send the lab
`
`preformulated l82,780?
`
`09:20AM
`
`K) C)
`
`A.
`
`i do not know.
`
`K) F1
`
`R)R)
`
`R) h)
`
`Q.
`
`Who would know?
`
`A.
`
`Possibly Dr. Kern.
`
`Q.
`
`Okay.
`
`And now the third person that you spoke to,
`
`was
`
`K) wk
`
`this be‘ore or a‘
`
`‘ter you talked to Jr.
`
`Vose?
`
`09:21AM
`
`K) U1
`
`A. Aj-er.
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 16
`
`

`
`DfiBOS T
`
`ON - MCPfiSKfiY
`
`886
`
`C)\oQ)‘Q0\U1uhI»K)IA
`
`09:21AM
`
`09:21AM
`
`B:
`
`(35*K3
`
`.
`
`.
`
`Who called who?
`
`called him.
`
`Did you have any communications
`
`in writing with this
`
`third person?
`
`A.
`
`Q.
`
`A.
`
`No.
`
`And what was the purpose o:
`
`calling this third person?
`
`i wanted to
`
`find ou
`
`t what
`
`the —— what was in the drug
`
`because
`
`i was getting ready
`
`to publish a paper.
`
`i was getting
`
`ready to wri'
`
`:e the paper
`
`, actually.
`
`Q.
`
`.And wha
`
`: did he tel
`
`l YOJ?
`
`F1 F1
`
`A.
`
`{e told
`
`me ‘-
`
`F1 K)
`
`Q.
`
`Do you recall the words he used?
`
`F: U)
`
`A.
`
`we
`
`Q p
`
`FA IA
`
`F: U!
`
`09:21AM
`
`.
`
`But he told you all of
`
`the excipients and their
`
`ercentages?
`
`FA 0\
`
`A.
`
`He told me what's in the paper:
`
`10 percent ethanol,
`
`09:21AM
`
`FA \J
`
`F: G)
`
`F: ‘O
`
`K) C)
`
`K) F1
`
`R)R)
`
`R) h)
`
`K) wk
`
`10 percent benzyl benzoate and 10 percent benzyl alcohol
`
`brought
`
`to volume with the castor oil.
`
`(Reading stopped.)
`
`MS.
`
`P"RonnoLo—M
`
`*:TITIOW*:S: Your Honor,
`
`i
`
`think there
`
`was a mista<e in reading that.
`
`THE
`
`CCHIRT:
`
`It‘
`
`s —— no,
`
`the court reporter took it
`
`down correc-ly,
`
`-haL's
`
`_ine.
`
`(Deposition read as
`
`"01
`
`'ows:)
`
`09:21AM
`
`K) U1
`
`Q.
`
`You don
`
`‘t recall wh
`
`I)
`ether or not he specified the units o;
`
`United States District Court
`
`Camden , New Jersey
`
`Astrazeneca Ex. 2049 p. 17
`
`

`
`D*'.L’OS T ON - MCT.*'.SK+'.Y
`
`887
`
`1 measure?
`
`2 A.
`
`I do not recall.
`
`3 Q.
`
`How did you know to contact this third person?
`
`4 A.
`
`I called the number that was —— that I had been given for
`
`09&QAM
`
`5 Dr. Vose.
`
`6 Q.
`
`And somebody else answered?
`
`7 A.
`
`I don't know if it was somebody else or if it was
`
`8 Dr. Vose.
`
`9 Q.
`
`So there —— you're saying —— i‘ "'m understanding you
`
`09umAM 10 correctly, you believe it's possible that it was Dr. Vose that
`
`11
`
`told you the makeup oj Lhe jormulation but you're not sure?
`
`12 A. Well, it was whoever answered the phone. That's all
`
`13
`
`can say abou- i-.
`
`14 Q.
`
`I see. But you called Dr. Vose's direct line?
`
`09umAM 15 A.
`
`Yeah.
`
`I called the same number
`
`I had called previously
`
`16 to speak with Dr. Vose.
`
`17 Q.
`
`"ho gave you Dr. Vose's phone number?
`
`18 A.
`
`Dr. Wakeling.
`
`19 Q.
`
`"ho gave you Dr. Wakeling's phone number?
`
`09umAM 20 A.
`
`i don't remember.
`
`21 Q.
`
`Do you recall generally how you knew to call Dr. Wakeling
`
`22
`
`that he was the person to call?
`
`23 A.
`
`Either Dr. Lippman or Dr. Kern told me, but
`
`I don't know
`
`24 who or when or anything.
`
`09uBAM 25 Q.
`
`But do I understand you correctly that you —— with regard
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 18
`
`

`
`DfiBOS T
`
`ON _
`
`888
`
`to this third person,
`
`that it was a man?
`
`A.
`
`Q.
`
`Yes.
`
`When you called
`
`Dr. Vose
`
`the
`
`first time,
`
`or when you
`
`calle
`
`d Dr. Vose,
`
`how did you know it was him that answered the
`
`M%23AM
`
`phone
`
`?
`
`A.
`
`Q.
`
`i don't remember.
`
`But you ‘eel
`
`COD"
`
`‘ident that you were speaking to
`
`Dr. Vose
`
`the f
`
`irst time?
`
`09:23AM
`
`A.
`
`Q.
`
`Well,
`
`' certainly believed that
`
`i was.
`
`At
`
`the time,
`
`did yo
`
`i believe that the third person that
`
`you were talking to was
`
`Dr.
`
`Vose?
`
`i don't recall what
`
`f believed.
`
`What do you believe today?
`
`i don't believe
`
`09:23AM
`
`You have no idea who you talked to?
`
`Right.
`
`Did you send As
`
`:raZeneca dra
`
`_,S O
`
`the study protocol
`
`that
`
`you were going
`
`_,O "ollow
`
`Ol’
`
`-he research described in
`
`McLes
`
`<ey 1998?
`
`09:23AM
`
`Did you ever provide your lab notebooks or raw data to
`
`Astra
`
`Zeneca?
`
`Did you record when you received samples from AstraZeneca
`
`09:23AM
`
`ir laboratory notebooks?
`
`United States District Court
`
`Camden,
`
`New Jersey
`
`Astrazeneca Ex. 2049 p. 19
`
`

`
`D*'.L’OS T ON - MCT.*'.SK+'.Y
`
`889
`
`1 A.
`
`I don't recall.
`
`2 Q. What was your general practice with regard to recording
`
`3
`
`4
`
`receipt of samples at the time you were postdoc in Dr. Kern's
`
`lab?
`
`09uMAM
`
`5 A.
`
`I would unpack them and if they needed refrigeration,
`
`6 would put
`
`them in the refrigerator or the freezer as
`
`7 appropriate.
`
`8 Q.
`
`Did you have a separate practice as to what you would
`
`9
`
`record about
`
`the samples received?
`
`09:24AM 10 A.
`
`No.
`
`11 Q. Was it your understanding from the beginning of your
`
`12 postdoc in Dr. Kern's lab that AstraZeneca was the source of
`
`13
`
`182,780 or was that something you learned later in time?
`
`14 A.
`
`At
`
`the beginning,
`
`I had no idea there was such a thing as
`
`09:24AM 15
`
`182,780.
`
`16 Q.
`
`How did you come to find out that?
`
`How did you come to
`
`17
`
`find out that AstraZeneca would supply 182,780 to the lab?
`
`18 A.
`
`I'm not sure.
`
`19 Q. What do you —— what is your best recollection?
`
`09uMAM 20 A.
`
`We had meetings of all the researchers,
`
`the breast cancer
`
`21
`
`researchers and it may have come up at that, one of those
`
`22 meetings.
`
`23 Q.
`
`From the Lombardi side of things, not
`
`the AstraZeneca
`
`24
`
`side of things, but
`
`from the Lombardi side of things, was
`
`09u5AM 25 procuring samples as simple as calling and asking for them, or
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 20
`
`

`
`DfiBOS T
`
`ON — Mcl
`
`fiSKfiY
`
`890
`
`C)\oQ)‘Q0\U1uhI»K)IA
`
`MMZSAM
`
`09:25AM
`
`B:
`
`was there an internal protocol that had to be
`
`followed
`
`first?
`
`A.
`
`Q.
`
`i was not aware o“
`
`an internal
`
`protocol.
`
`Do yo; know how long i-
`
`-ook in between the time you
`
`talked to Dr. Wakeling and
`
`-he Lime Lha- you received the
`
`powdered
`
`C
`
`187,780?
`
`A.
`
`Q.
`
`think it was a matter of
`
`weeks.
`
`Do you recall how long it took
`
`:rom the time you talked
`
`to Dr. Vose to th n r c iv
`
`th pr
`
`fo
`
`rmulated C
`
`187,780?
`
`A.
`
`Probably about
`
`the same.
`
`Q.
`
`And yoi personally do not recall
`
`filling out any
`
`forms or
`
`F1 F1
`
`signing anything in regard to samples,
`
`correct?
`
`F1 K)
`
`A. Correct.
`
`F: U)
`
`FA IA
`
`F: U!
`
`09:25AM
`
`Q.
`
`i want
`
`to make sure we're absolutely on the same page.
`
`So before you s-ar-ed,
`
`at any
`
`time, did you send
`
`AstraZeneca a sLaLemen- o_ proposed investigation
`
`forms?
`
`H: 0\
`
`A.
`
`Wo
`
`FA \J
`
`F: G)
`
`Q.
`
`Do you know whether or not
`
`Dr.
`
`Kern had sent AstraZeneca
`
`a sLa-emenL of proposed investigation
`
`forms?
`
`F: ‘O
`
`A.
`
`Wo
`
`09:25AM
`
`09:26AM
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`Q.
`
`Wo, you do not know, or no,
`
`he did not?
`
`A.
`
`Wo,
`
`i don't know.
`
`Q.
`
`Did you fill out any other forms
`
`for Astraneneca before
`
`you started your work on McLeskey 1998?
`
`Do you know whether anyone else in your group filled out
`
`United States District Court
`
`Camden , New Jersey
`
`Astrazeneca Ex. 2049 p. 21
`
`

`
`D*'.L’OS T ON - MCT.*'.SK+'.Y
`
`891
`
`1
`
`any other ‘orms ‘or Astrafleneca?
`
`2 A.
`
`I don't know.
`
`3 Q.
`
`?e‘ore starting the work on --
`
`4 A.
`
`I don't know.
`
`I know nothing.
`
`09umAM
`
`5 Q.
`
`Did you personally ever request any samples from
`
`6 AstraZeneca in writing?
`
`7 A.
`
`No.
`
`8 Q.
`
`Okay.
`
`So you received powdered
`
`C
`
`l87,78O from Dr. Alan
`
`9 Wakeling, correct?
`
`09umAM 10 A. Correct.
`
`11 Q.
`
`Did Dr. Wakeling send the powdered samples directly to
`
`12
`
`you?
`
`13 A.
`
`I don't recall.
`
`I got
`
`them, but
`
`I don't remember who
`
`14
`
`they were addressed to.
`
`09fl%AM 15 Q.
`
`You don't have a speci‘ic recollection o‘ whether they
`
`H 0\
`
`came directly to you or whether Dr. Kern gave them to you?
`
`|~\ \l A.
`
`I opened the pac<age, or I got
`
`the package.
`
`I don't know
`
`H U)
`
`1'
`
`" got
`
`the package from a mailman or ‘rom Dr. Kern.
`
`" don't
`
`H KO
`
`know.
`
`09uflAM 20 Q.
`
`Okay. But you opened the package?
`
`21
`
`.A.
`
`Yeah.
`
`22 Q.
`
`Do you recall approximately when that was when you opened
`
`23 the package?
`
`24 A.
`
`No.
`
`09QNAM 25 Q. Was it in 1997?
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 22
`
`

`
`DfiBOS T
`
`ON - MCPfiSKfiY
`
`892
`
`A.
`
`Oh, no.
`
`I
`
`t was way before that.
`
`Q.
`
`Way before
`
`that?
`
`So 1996,
`
`l995?
`
`A.
`
`It was bef
`
`ore 1993.
`
`Q. Qefore 199
`
`3?
`
`A.
`
`Yes.
`
`Q
`
`.
`
`How was the powder sample packaged?
`
`Was it in a —— a
`
`bottle or —— ho
`
`w did it arrive,
`
`do you recall?
`
`A.
`
`think it was just in a little jar.
`
`Q. Would the
`
`receipt of that sample have been logged in the
`
`C)\oQ)‘Q0\U1uhI»K)IA
`
`B:
`
`lab?
`
`F1 F1
`
`A.
`
`No.
`
`09:27AM
`
`09:27AM
`
`F1 K)
`
`F: U)
`
`Q.
`
`Now,
`
`if
`
`' understand you correctly,
`
`Dr. Wakeling gave you
`
`information on
`
`administration of
`
`the drug, correct?
`
`FA IA
`
`A. Correct.
`
`09:27AM
`
`F: U!
`
`H: 0\
`
`FA \J
`
`Q.
`
`Did Dr.
`
`Wakeling send you instructions on how '
`
`I)
`formulate the 50—milligram per milliliter concentration o;
`
`C
`
`187,780 and ethanol and peanut oil?
`
`F: G)
`
`A.
`
`ie didn't
`
`send them to me,
`
`I10.
`
`F: ‘O
`
`Q.
`
`Did he send you instructions regarding making the
`
`09:28AM
`
`K) C)
`
`formulation?
`
`K) F1
`
`A.
`
`\o.
`
`R)R)
`
`Q.
`
`ow did you know to do that?
`
`R) h)
`
`A.
`
`e told me
`
`over the phone.
`
`K) wk
`
`K) U1
`
`09:28AM
`
`Q.
`
`Okay.
`
`So
`
`Dr.
`
`Wa<eling told you how to administer it,
`
`and
`
`he also told yo
`
`1 how to make the
`
`formulation that's recorded
`
`United States District Court
`
`Camden , New Jersey
`
`Astrazeneca Ex. 2049 p. 23
`
`

`
`DfiBOS T ON - MCLfiSKfiY
`
`893
`
`in McLeskey 1998 concerning ethanol and peanut oil?
`
`A.
`
`Q.
`
`Exactly.
`
`And you testified earlier,
`
`i think,
`
`that you were
`
`actually the person that had actually dissolved the
`
`09flRAM
`
`C
`
`189,780 in ethanol and then spiked it into the peanut oil?
`
`A. Correct.
`
`Q.
`
`Why did you use a concentration of 50—milligrams per
`
`milliliter?
`
`A.
`
`Because that's what Dr. Wakeling said to do.
`
`09flRAM
`
`Q.
`
`Dr. Wakeling did not discuss any sort o" con"idenLialiLy
`
`with you --
`
`A.
`
`No.
`
`Q.
`
`—— when —— when you spoke with him?
`
`A.
`
`No --
`
`09flRAM
`
`Q.
`
`Sorry, it needs to be verbal.
`
`A.
`
`Sorry, no.
`
`Q.
`
`"‘ you'll turn to Page 698 o‘ ?xhibit 5, do you see a
`
`paragraph headed,
`
`the title Drugs, and then about seven lines
`
`down, w
`
`s
`
`:h
`
`lin d s nt nc
`
`for the experiments depicted
`
`09flBAM
`
`in Figure l,
`
`3 and C, 50—milligram per milliliter
`
`pre
`
`formulated drug in a vehicle o: 10 percent ethanol, 15
`
`percent benzyl benzoate,
`
`10 percent benzyl alcohol brought
`
`to
`
`volume by castor oil was supplied by 3.M. Vose, Zeneca
`
`Pharmaceuticals.
`
`09flBAM
`
`Do you see that?
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 24
`
`

`
`D*'.L’OS T ON - MCT.*'.SK+'.Y
`
`894
`
`1 A.
`
`Yes.
`
`2 Q.
`
`Is this the preformulated drug that we were just
`
`3 discussing that you procured via telephone conference with
`
`4 Dr. Vose?
`
`09:29AM
`
`5 A.
`
`Yes.
`
`6 Q. Approximately when did you receive the preformulated
`
`7
`
`C
`
`187,780 from Dr. Vose?
`
`8 A. All
`
`I can tell you is it was before 1993.
`
`9 Q.
`
`The preformed —— both —— you received both the powdered
`
`09umAM 10
`
`C
`
`and the preformulated C before 1993.
`
`Is that what
`
`11 you're saying?
`
`12 A.
`
`Yes.
`
`13 Q.
`
`How do you know that it was before 1993?
`
`14 A.
`
`In 1993,
`
`I received a facul-y appointment, and then I was
`
`09:%mM 15
`
`no longer a postdoc. And at that point,
`
`the animal
`
`16 experiments were done.
`
`17 Q. Were you the person that opened the package of the
`
`18 preformulated C
`
`187,780?
`
`19 A.
`
`Yes.
`
`09u%mM 20 Q.
`
`Do you recall how many preformulated samples were sent
`
`to
`
`21
`
`you?
`
`22 A.
`
`W0
`
`23 Q.
`
`Do you recall if those samples were in vials?
`
`24 A.
`
`Wo
`
`09:%mM 25 Q.
`
`{ow were —— how were the preformulated samples packaged?
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 25
`
`

`
`DfiBOS T
`
`ON - MCPfiSKfiY
`
`895
`
`C)\oQ)‘Q0\U1uhI»K)IA
`
`09fiNAM
`
`09KflAM
`
`B:
`
`F1 F1
`
`F1 K)
`
`F: U)
`
`A.
`
`I don't recall.
`
`What documentation accompanied the preformulated
`
`C
`
`187,780?
`
`i don't recall.
`
`Do you recall
`
`whether or
`
`not there was documentation
`
`included with the preformulated C
`
`187,780?
`
`i don‘: recall.
`
`Q.
`
`you wanted to try to remember,
`
`who would you talk to?
`
`Nobody.
`
`i mean,
`
`i —— there's nobody.
`
`think it's lost
`
`to posterity.
`
`Q.
`
`So do
`
`i understand correct
`
`ly that at the time you
`
`received the preformulated C
`
`’87,780, you did not know what
`
`excipients were present in the
`
`formulation —— in that
`
`FA Q
`
`formulation?
`
`09KflAM
`
`F: U!
`
`A. Correct.
`
`H: 0\
`
`Q.
`
`Did you have an understanding that the preformulated
`
`FA \J
`
`C
`
`187,780 could not be used
`
`in humans?
`
`F: G)
`
`A.
`
`Nothing we had in our lab could be used in humans.
`
`F: ‘O
`
`K) C)
`
`09KflAM
`
`Q. Were you given speci‘ic
`
`instructions ‘rom AstraZeneca
`
`that it should not be used in
`
`humans?
`
`K) F1
`
`A.
`
`i don't recall.
`
`R)R)
`
`Q.
`
`Turning back to Page 698
`
`in the drug section again, you
`
`R) h)
`
`K) wk
`
`see the text that says,
`
`In a vehicle o:
`
`10 percent ethanol,
`
`l5
`
`percent benzyl benzoate,
`
`10 percent benzyl alcohol brought
`
`to
`
`09KflAM
`
`K) U1
`
`volume with castor oil.
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 26
`
`

`
`DfiBOS T ON - MCPfiSKfiY
`
`896
`
`OWWV0\(MAmNH
`
`09KflAM
`
`09fiflAM
`
`H
`
`Do you recall who actially wrote that text?
`
`T did.
`
`Did you test or analyze the formulation in any way?
`
`Wo.
`
`"ere you told that the preformulated C
`
`’87,78O that you
`
`A.
`
`Q.
`
`A.
`
`Q.
`
`received should not be administered intramuscularly?
`
`A.
`
`Q.
`
`the
`
`i was told to administer it sibcutaneously to my --
`
`When the person who answered Dr. Vose's phone gave you
`
`excipients present
`
`in the preformulated C
`
`187,780,
`
`were
`
`you sworn to secrecy?
`
`H H
`
`A.
`
`No.
`
`H K)
`
`Q.
`
`Why did you want
`
`to include those details in McLeskey
`
`F: U)
`
`1998?
`
`09fiflAM
`
`FA Q
`
`F: U!
`
`FA 0\
`
`FA \J
`
`A.
`
`That's how I was instructed to write a paper when I was
`
`in my predoctoral, was to include such things.
`
`Q.
`
`Have you searched your personal
`
`‘files ‘or all documents
`
`relating to either the powdered
`
`C
`
`187,780 received or the
`
`F: G)
`
`pre
`
`formulated C
`
`187,780 that you received?
`
`F: ‘O
`
`A.
`
`i don't have any personal
`
`"1 es about this.
`
`09fiflAM
`
`K) C)
`
`Q.
`
`Did Z understand you correctly that you do not recall
`
`K) F1
`
`R)R)
`
`whether or not
`
`the person that answered
`
`Dr. Vose's phone told
`
`you that th p rc ntag s w r
`
`in weight
`
`to volume or
`
`R) h)
`
`volume—:o—volume?
`
`K) wk
`
`K) U1
`
`09fiBAM
`
`i do not recall.
`
`Did you assume that th p rc ntag s w r
`
`ith r in weight
`
`United States District Court
`
`Camden, New Jersey
`
`Astrazeneca Ex. 2049 p. 27
`
`

`
`D*'.L’OS T ON - MCT.*'.SK+'.Y
`
`897
`
`to volume or volume—to—volime?
`
`A.
`
`I don't think I ever thought about it one way or the
`
`other.
`
`Q.
`
`Have you thought about it since McLeskey l998 was
`
`09:33AM
`
`published?
`
`A.
`
`Yes, but
`
`I have no basis for knowing which way it was.
`
`Q.
`
`So as you sit here today, you don't know whether or not
`
`th p rc ntag s w r
`
`in weight
`
`to volume or volume—to—volume?
`
`A.
`
`I do not know.
`
`09mBAM
`
`Q.
`
`So what did you mean when you said "These studies
`
`indicate that estrogen independence may be achieved"?
`
`A.
`
`I meant that in our engineered model, we achieved
`
`estrogen—independent
`
`tumor growth in mice through engineering
`
`the cell to express in FGF.
`
`09mBAM
`
`Q.
`
`So in the context of your experiment, you wanted to use
`
`the aromatase inhibitors and
`
`C
`
`187,780 to shut down any
`
`remaining estrogen that might have been present?
`
`A.
`
`Yes.
`
`Q.
`
`And you wanted to shut down any remaining estrogen so
`
`09 MAM
`
`that you could isolate or investigate the estrogen independent
`
`cell

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket